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1Although it is associated with risk factors that act sys-temically (eg, hypercholesterolemia, smoking, age), 
atherosclerosis is a focal disease that develops preferentially 
near branches and bends of arteries.1 The physiology of 
endothelial cells (EC) varies considerably according to their 
location in the arterial tree. EC at regions that are predis-
posed to lesion formation (atheroprone) are characterized by 
relatively high rates of proliferation2–4 and proinflammatory 
activation.5–9 These features, which we refer to as endothelial 
dysfunction, promote early atherogenesis by increasing the 
accessibility of the vessel wall to leukocytes and its perme-
ability to cholesterol-rich lipoproteins10 that are key drivers 
of atherogenesis. By contrast, EC at atheroprotected sites 
remain quiescent and are resistant to inflammatory activa-
tion.1–9 The spatial localization of EC phenotypes and ath-
erosclerosis is tightly linked to local hemodynamics. Blood 
flow generates a frictional force at the endothelial surface 
called wall shear stress that varies in magnitude and direction 
according to vascular anatomy. Atheroprotected regions of 
arteries with relatively uniform geometry are exposed to high 
time-averaged shear stress that is unidirectional, whereas 
atheroprone sites near branches and bends are exposed to 
complex flow patterns generating low time-averaged shear 
stress that varies in direction (eg, oscillatory bidirectional and 
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Objective—Atherosclerosis develops near branches and bends of arteries that are exposed to low shear stress (mechanical 
drag). These sites are characterized by excessive endothelial cell (EC) proliferation and inflammation that promote lesion 
initiation. The transcription factor HIF1α (hypoxia-inducible factor 1α) is canonically activated by hypoxia and has a role 
in plaque neovascularization. We studied the influence of shear stress on HIF1α activation and the contribution of this 
noncanonical pathway to lesion initiation.
Approach and Results—Quantitative polymerase chain reaction and en face staining revealed that HIF1α was expressed 
preferentially at low shear stress regions of porcine and murine arteries. Low shear stress induced HIF1α in cultured EC 
in the presence of atmospheric oxygen. The mechanism involves the transcription factor nuclear factor-κB that induced 
HIF1α transcripts and induction of the deubiquitinating enzyme Cezanne that stabilized HIF1α protein. Gene silencing 
revealed that HIF1α enhanced proliferation and inflammatory activation in EC exposed to low shear stress via induction 
of glycolysis enzymes. We validated this observation by imposing low shear stress in murine carotid arteries (partial 
ligation) that upregulated the expression of HIF1α, glycolysis enzymes, and inflammatory genes and enhanced EC 
proliferation. EC-specific genetic deletion of HIF1α in hypercholesterolemic apolipoprotein E–defecient mice reduced 
inflammation and endothelial proliferation in partially ligated arteries, indicating that HIF1α drives inflammation and 
vascular dysfunction at low shear stress regions.
Conclusions—Mechanical low shear stress activates HIF1α at atheroprone regions of arteries via nuclear factor-κB 
and Cezanne. HIF1α promotes atherosclerosis initiation at these sites by inducing excessive EC proliferation and 
inflammation via the induction of glycolysis enzymes.  (Arterioscler Thromb Vasc Biol. 2017;37:00-00. DOI: 10.1161/
ATVBAHA.117.309249.)
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biaxial flow).9,11 The application of flow to cultured cells has 
revealed a causal relationship between flow and EC physi-
ology. Atheroprotective flow patterns induce numerous cod-
ing and noncoding RNAs that induce quiescence and reduce 
inflammation, whereas atheroprone flow activates multiple 
signaling pathways and transcription factors that promote EC 
dysfunction and inflammation.12
The transcription factor HIF1α (hypoxia-inducible factor 
1α) is a central regulator of cellular responses to hypoxia. In 
cells exposed to physiological levels of oxygen (normoxia), 
HIF1α is modified with hydroxyl groups by prolyl hydrox-
ylase domain (PHD) enzymes, thus targeting it for rapid 
ubiquitination and degradation.13–16 However, this oxygen-
dependent process is inactivated in conditions of hypoxia, 
leading to HIF1α accumulation. HIF1α plays an essential 
role during angiogenesis by inducing vascular endothelial 
growth factor and other growth factors, thereby enhancing 
perfusion of ischemic tissues to restore oxygenation.17 Of 
note, this process also requires HIF1α-dependent induction 
of multiple glycolytic enzymes,18 thus causing a metabolic 
switch that allows ATP and macromolecules to be gener-
ated by glycolysis under anaerobic conditions.19–21 HIF1α is 
expressed in advanced atherosclerotic plaques,22 and a recent 
study demonstrated that genetic deletion of HIF1α from EC 
reduced experimental atherosclerosis in a murine model.23 
However, the potential role of HIF1α in focal EC dysfunc-
tion and inflammation linked to early atherogenesis has not 
been studied.
Here, we show for the first time that HIF1α can be activated 
in EC by mechanical low shear stress, leading to enrichment 
of HIF1α expression at atheroprone regions of arteries. HIF1α 
is upregulated via a dual mechanism involving transcriptional 
activation by nuclear factor (NF)-κB and stabilization via the 
deubiquitinating enzyme Cezanne. At a functional level, we 
demonstrate that HIF1α drives atherogenic processes at predi-
lection sites by enhancing inflammation and inducing exces-
sive EC proliferation via upregulation of glycolysis enzymes. 
Thus, mechanical activation of HIF1α is a novel mechanism 
for the focal induction of atherosclerosis. This pathway could 
potentially provide a novel target to prevent or treat early 
atherosclerosis.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Animals
EC from high (outer) or low (inner curvature) shear stress regions of 
porcine aortae were isolated.24 HIF1α was deleted from EC of apo-
lipoprotein E–defecient (ApoE−/−) mice (called HIF1αEC-cKO) using 
tamoxifen,23 and the left carotid artery was partially ligated25 before 
high-fat feeding. The expression of specific proteins was assessed 
by en face staining3,7,8,24,26 or by immunostaining of carotid artery 
cross-sections.23
Cultured EC
Human umbilical vein EC were transfected with small interfering 
RNA24,26 or with expression vectors containing IκBα (nuclear fac-
tor of kappa light polypeptide gene enhancer in B-cells inhibitor, 
alpha; pCMV-IκBα, GFP [green fluorescent protein]-Cezanne, or 
GFP-Cezanne Cys/Ser [catalytically inactive]).27 Human umbilical 
vein EC and human coronary artery EC were exposed to flow using 
orbital shaking or an Ibidi parallel plate system.24,26,28 Quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) was per-
formed using gene-specific primers (Table I in the online-only Data 
Supplement), and immunofluorescent staining, Western blotting, 
and chromatin immunoprecipitation were performed with specific 
primary antibodies (Table II in the online-only Data Supplement). 
Glycolysis was monitored using the Seahorse system.29
Results
HIF1α and Glycolysis Enzymes Are 
Expressed at Atheroprone Sites
A recent study from our laboratory revealed >800 transcripts that 
were differentially expressed between EC at atheroprone (low 
shear stress; inner curvature of arch) and atheroprotected (high 
shear stress; outer curvature) regions of the porcine aorta.24 It 
suggested that HIF1α and several of its target genes were upreg-
ulated at the atheroprone site. To validate this observation, we 
performed qPCR studies of an independent cohort of pigs and 
demonstrated that EC isolated from the low shear stress region 
had enriched expression of HIF1α and several downstream 
targets, including the glycolysis regulator 6-phosphofructo-
2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), glycolysis 
enzymes (hexokinase 2 [HK2], enolase 2), and glucose trans-
porters (glucose transporter 1, glucose transporter 3; Figure 1A).
We also performed en face staining of the murine aortic 
endothelium to quantify the expression of HIF1α at sites that 
are known to be exposed to low (inner curvature of arch) or 
high (curvature) shear stress.11 It demonstrated that HIF1α 
protein was expressed at higher levels at a low shear com-
pared with a high shear stress site (Figure 1B, top). Tiling of 
multiple fields of view revealed a sharp delineation in HIF1α 
expression, which was observed in EC exposed to low shear 
stress (note nonaligned nuclei) but not in EC exposed to high 
shear stress (aligned nuclei; Figure I in the online-only Data 
Supplement). It was concluded that HIF1α was active at the 
low shear region as a portion of the cellular pool localized to 
the nucleus (Figure 1B, top, arrows); in addition, the expres-
sion of HK2 and enolase 2 target molecules was also enriched 
at the low shear site (Figure 1B, center and bottom). The influ-
ence of atherogenesis on HIF1α expression was studied using 
ApoE−/− mice exposed to a high-fat diet for 6 weeks. En face 
staining revealed that HIF1α was expressed in EC overlying 
plaques and that the level of expression at the low shear region 
was similar in wild-type and ApoE−/− mice (Figure II in the 
online-only Data Supplement). Thus, we conclude that HIF1α 
Nonstandard Abbreviations and Acronyms
ApoE−/− apolipoprotein E–defecient
EC endothelial cell
HIF1α hypoxia-inducible factor 1α
HK2 hexokinase 2
LCA left carotid artery
NF nuclear factor
PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
PHD prolyl hydroxylase domain
qRT-PCR quantitative reverse transcription polymerase chain reaction
VHL Von Hippel Lindau
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A
B
Figure 1. Enrichment of HIF1α (hypoxia-inducible factor 1α) and glycolytic enzymes at atheroprone sites. The expression of HIF1α and 
several of its target genes was quantified at low wall shear stress (WSS; inner curvature) and high WSS (outer curvature) regions of the 
porcine aorta by quantitative reverse transcription polymerase chain reaction (A) and en face staining of the mouse aorta (B). Mean 
levels±SEM are shown for n=5 pigs and n=3 mice. In representative images, endothelial cells were identified by costaining with anti-CD31 
antibodies conjugated to fluorescein isothiocyanate (green). Cell nuclei were identified using TOPRO3 (blue). Arrows indicate nuclear 
HIF1α. Differences between means were analyzed using a paired t test. ENO2 indicates enolase 2; GLUT, glucose transporter; HK2, hexo-
kinase 2; and PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3.
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and downstream glycolysis genes are expressed preferentially 
at low shear atheroprone sites and that HIF1α expression is 
maintained during early atherogenesis.
Low Shear Stress Induces HIF1α in 
Conditions of Atmospheric Oxygen
Given its expression at atheroprone sites, we hypothesized 
that HIF1α is regulated by shear stress. In preliminary studies, 
we validated the detection of HIF1α by Western blotting by 
demonstrating that anti-HIF1α antibodies recognize a single 
band (at ≈120 kDa) in cells treated with the PHD inhibitor 
dimethyloxalylglycine and that this band was suppressed by 
small interfering RNA sequences designed to target HIF1α 
(with no effect on HIF2α; Figure III in the online-only Data 
Supplement). The potential relationship between shear stress 
and HIF1α was investigated using cultured EC exposed to flow 
in the presence of atmospheric oxygen. Two complimentary 
systems were used: an orbital system that generates regions of 
lower shear stress (5 dyn/cm2) with variation in direction at the 
center and higher unidirectional shear stress (11 dyn/cm2) at 
the periphery28 and a parallel plate system that was used to gen-
erate unidirectional shear stress of 4 or 13 dyn/cm2. Although 
these shear stress magnitudes are within the physiological 
range, they are referred to as low (4–5 dyn/cm2) and high (11–
13 dyn/cm2) shear stress, respectively, for the sake of brevity. 
We have previously validated both the orbital and parallel plate 
systems; for example, high shear stress reduces apoptosis by 
inducing antiapoptotic genes.24 First, we demonstrated using 
the orbital system that HIF1α expression was elevated in EC 
exposed to low shear conditions compared with cells exposed 
to high shear or static conditions (Figure 2A, left). Similarly, 
exposure of EC to flow using a parallel plate apparatus revealed 
enhanced expression of HIF1α in cells exposed to low oscilla-
tory compared with high uniform shear stress (Figure 2B). We 
confirmed by piminidazole staining that these flow conditions 
did not induce hypoxia (Figure IV in the online-only Data 
Supplement). However, the induction of HIF1α in response 
to dimethyloxalylglycine (a hypoxia mimic) was elevated 
in EC exposed to low shear compared with cells exposed to 
high shear (Figure 2A, right). Thus, it was concluded that low 
shear stress induces HIF1α expression and also primes EC for 
enhanced HIF1α activation in response to hypoxic signaling.
NF-κB and Cezanne-Dependent Mechanism Induce 
and Stabilize HIF1α Under Low Shear Stress
The mechanism linking low shear stress to HIF1α upregula-
tion was investigated. qRT-PCR revealed that HIF1α mRNA 
levels were significantly elevated in human umbilical vein EC 
exposed to low or low oscillatory shear stress using the orbital 
(Figure 3A) or parallel plate (Figure 3B) systems compared 
with cells exposed to high shear stress or static conditions, 
indicating that low shear stress induces HIF1α at the transcript 
level. Similarly, HIF1α mRNA levels were elevated in human 
coronary artery EC exposed to low shear stress compared with 
cells exposed to high shear stress or static conditions (Figure 
V in the online-only Data Supplement). We hypothesized that 
flow regulates HIF1α mRNA via NF-κB, a transcription fac-
tor that can induce HIF1α in response to inflammatory sig-
naling.30,31 In support of this, DNA-binding enzyme-linked 
immunosorbent assay revealed that low shear stress activated 
RelA and p50 subunits in cultured EC (Figure 3C). A direct 
link between NF-κB and HIF1α expression was established 
using an expression plasmid containing IκBα, which inhibited 
NF-κB activity in transfected EC (Figure VI in the online-only 
Data Supplement). Overexpression of IκBα reduced HIF1α 
expression in EC exposed to low shear stress, whereas an 
empty control plasmid had no effect (Figure 3D), indicating 
that NF-κB positively regulated HIF1α under low shear con-
ditions. Similarly, silencing of RelA NF-κB subunits reduced 
HIF1α expression in EC exposed to low shear (Figure 3E). 
A B
Figure 2. Low shear stress induced HIF1α (hypoxia-inducible factor 1α). A, Human umbilical vein endothelial cells (HUVEC) were exposed 
to orbital flow to generate low (5 dyn/cm2) or high (11 dyn/cm2) wall shear stress (WSS) or were maintained under static conditions. After 
72 h, they were exposed to dimethyloxalylglycine (DMOG) for 4 h or remained untreated. B, Alternatively, HUVEC were exposed to high 
(13 dyn/cm2) or low oscillatory (4 dyn/cm2; 0.5 Hz) WSS for 72 h using a parallel plate system. A and B, The expression levels of HIF1α 
were assessed by Western blotting using specific antibodies, and anti-Calnexin or anti-PDHX (pyruvate dehydrogenase complex compo-
nent X) antibodies were used to control for total protein levels. Representative blots are shown. Bands were quantified by densitometry. 
Data were pooled from 3 independent experiments, and mean HIF1α expression±SEM is shown. Differences between means were ana-
lyzed using a paired t test or 1-way ANOVA with the Bonferroni correction for multiple pairwise comparisons.
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Finally, chromatin immunoprecipitation studies demonstrated 
that HIF1α promoter sequences coprecipitated with antihis-
tone H3 antibodies (positive control) and anti-RelA antibod-
ies but did not coprecipitate with control IgG in EC exposed 
to orbital flow (Figure 3F), indicating that RelA interacts 
with the HIF1α promoter under low shear stress conditions. 
Collectively, these observations indicate that low shear stress 
induces HIF1α mRNA via an NF-κB–dependent process.
A
C
E
F
D
B
Figure 3. Nuclear factor-κB induced HIF1α (hypoxia-inducible factor 1α) mRNA in response to low shear stress. Human umbilical vein 
endothelial cells (HUVEC) were exposed to low or high wall shear stress (WSS) for 72 h using an orbital (5 vs 11 dyn/cm2; A) or parallel 
plate (4 vs 13 dyn/cm2; B) system. A and B, The expression levels of HIF1α mRNA were assessed by quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). Mean HIF1α expression±SEM is shown. C, HUVEC were exposed to orbital flow to generate low 
or high WSS. After 72 h, the activity of RelA and p50 was assessed by DNA-binding enzyme-linked immunosorbent assay. Mean opti-
cal density (OD) 450 nm values±SEM are shown. D, HUVEC were transfected using pCMV-IκBα or with an empty plasmid or remained 
untreated as a control. E, HUVEC were transfected with small interfering RNA (siRNA) targeting RelA or with scrambled sequences. D and 
E, Cells were exposed to low WSS using the orbital system. After 72 h, the expression levels of HIF1α or RelA mRNA were assessed by 
qRT-PCR. Mean expression±SEM is shown. F, Nuclear lysates prepared from HUVECs exposed to orbital flow for 72 h were incubated 
with anti-RelA, antihistone H3, or irrelevant control antibodies before precipitation. The levels of HIF1α promoter DNA in precipitates and 
in nonprecipitated lysates (input) were assessed by comparative real-time PCR. Mean levels (SEM) are shown. A–F, Data were pooled 
from 3 independent experiments. Differences between means were analyzed using a 1-way ANOVA with the Bonferroni correction for 
multiple pairwise comparisons (A, B, D, E, F) or a paired t test (C).
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We reasoned that low shear stress must also prevent HIF1α 
degradation to enhance its expression at the protein level. To 
identify the mechanism, we examined the effects of flow on 
the expression of PHD proteins and Von Hippel Lindau (VHL) 
E3 ubiquitin ligase which destabilize HIF1α by modifying it 
with hydroxyl groups and ubiquitin, respectively.13–15 Western 
blotting revealed that PHD1, PHD3, and VHL were not sup-
pressed by low shear stress (data not shown), indicating that 
HIF1α accumulation under these conditions is not mediated 
by reduced hydroxylation or ubiquitination. However, HIF1α 
can be stabilized by the deubiquitinating enzyme Cezanne that 
rescues it from degradation.32 The expression of Cezanne in 
cultured EC exposed to flow was studied by Western blotting. 
Antibodies against the N-terminal portion generated bands at 
≈95 and ≈105 kDa (Figure 4), which were confirmed to result 
from Cezanne expression by gene silencing (Figure VII in the 
online-only Data Supplement). It was concluded that Cezanne 
is expressed at significantly higher levels in EC exposed to low 
shear stress compared with cells exposed to high shear stress or 
static conditions (Figure 4A and 4B). Similarly, qRT-PCR dem-
onstrated that Cezanne mRNA levels were enhanced under low 
compared with high shear stress (Figure 4C and 4D). These 
observations were validated by qRT-PCR analysis of EC iso-
lated from regions of the porcine aortic arch (Figure 5A) and 
en face staining of the murine aortic endothelium (Figure 5B; 
Figure I in the online-only Data Supplement), which demon-
strated that Cezanne protein was expressed at higher levels at 
low shear compared with high shear stress sites.
To assess whether Cezanne is responsible for stabilizing 
HIF1α under low shear stress, we transfected cells with a 
dominant negative form that is mutated at the catalytic cysteine 
(GFP-Cezanne Cys/Ser). Immunofluorescent staining revealed 
A
C D
B
Figure 4. Low shear stress induced Cezanne. A and C, Human umbilical vein endothelial cells (HUVEC) were exposed to orbital flow to 
generate low (5 dyn/cm2) or high (11 dyn/cm2) wall shear stress (WSS) or were maintained under static conditions. B and D, Alternatively, 
HUVEC were exposed to high (13 dyn/cm2) or low (4 dyn/cm2) WSS for 72 h using a parallel plate system. A and B, The expression levels 
of Cezanne were assessed by Western blotting using specific antibodies, and anti-PDHX (pyruvate dehydrogenase complex component X) 
antibodies were used to control for total protein levels. Representative blots are shown. Bands were quantified by densitometry. Data were 
pooled from 3 independent experiments, and mean Cezanne expression±SEM is shown. C and D, The expression levels of Cezanne mRNA 
were assessed by quantitative reverse transcription polymerase chain reaction. Data were pooled from 3 independent experiments, and 
mean expression±SEM is shown. Differences between means were analyzed using a 1-way ANOVA with the Bonferroni correction for mul-
tiple pairwise comparisons (A) or a paired t test (B–D).
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that the expression of HIF1α was reduced by expression of 
GFP-Cezanne Cys/Ser and increased by GFP-Cezanne (wild 
type) compared with control GFP-transfected cells (Figure 6A), 
indicating that Cezanne activity is required to enhance HIF1α 
protein expression under low shear stress conditions. The 
effects of Cezanne on HIF1α ubiquitination were assessed by 
Western blotting of HIF1α immunoprecipitates generated from 
EC exposed to orbital flow. The abundance of high molecular 
weight forms of HIF1α and coprecipitating polyubiquitin was 
enhanced by expression of GFP-Cezanne Cys/Ser compared 
with expression of GFP-Cezanne or GFP alone (Figure 6B). 
These data are consistent with the hypothesis that Cezanne 
can target HIF1α for deubiquitination in EC exposed to low 
shear stress. Consistent with these observations, silencing of 
Cezanne significantly reduced HIF1α expression at the protein 
level (Figure 6C) but not at the mRNA level (Figure VIII in 
the online-only Data Supplement) in EC exposed to low shear 
stress. In conclusion, HIF1α is upregulated by low shear stress 
via dual processes that induce it at a transcriptional level via 
NF-κB and enhance it at the protein level via Cezanne.
HIF1α Promotes Glycolysis Under 
Low Shear Conditions
HIF1α drives angiogenesis by inducing a glycolytic switch,17–21 
and we wondered whether this process can also be induced 
by low shear stress. qRT-PCR and Western blotting revealed 
that several glycolysis regulators, including HK2, enolase 2, 
and PFKFB3, were induced in cultured EC by the applica-
tion of low shear stress (Figure 7A and 7C). Their expression 
was reduced by silencing of HIF1α (Figure 7B and 7C) or 
by silencing of Cezanne (Figure VIII in the online-only Data 
Supplement) and enhanced in cells exposed to dimethyloxa-
lylglycine (Figure IX in the online-only Data Supplement), 
indicating that Cezanne-HIF1α signaling activates glycolysis 
genes in EC exposed to low shear stress.
To study the influence of shear stress on glycolysis directly, 
we applied flow to cultured EC for 72 hours and then monitored 
extracellular acidification rate using a Seahorse XF analyzer.29 
In the presence of glucose, glycolytic extracellular acidifica-
tion rate was elevated in EC exposed to low compared with 
high shear stress (Figure 7D). In addition, glycolytic capacity, 
which is the ability of the glycolytic pathway to upregulate in 
time of energy need, was assessed after the addition of oligo-
mycin that is a specific inhibitor of the mitochondrial ATP syn-
thase. Glycolytic capacity was also higher in cells exposed to 
low shear stress compared with those cultured under high shear 
(Figure 7D). As a control, the glucose analogue 2 deoxyglu-
cose (an inhibitor of glycolysis) was used to inhibit glycolysis 
and establish the nonglycolytic extracellular acidification rate. 
Collectively, these data indicate that low shear stress drives gly-
colysis via HIF1α-dependent induction of glycolytic enzymes.
HIF1α-Dependent Glycolysis Enhanced 
Proliferation and Inflammation in EC 
Exposed to Low Shear Stress
We next investigated whether HIF1α-dependent glycolysis 
influences EC proliferation and inflammation because these pro-
cesses are involved in the initiation of atherosclerosis at low shear 
A
B
Figure 5. Enrichment of Cezanne at an atheroprone site. The 
expression of Cezanne was quantified at low wall shear stress 
(WSS; inner curvature) and high WSS (outer curvature) regions of 
the porcine aorta by quantitative reverse transcription polymerase 
chain reaction (A) and en face staining of the mouse aorta (B). 
Mean levels±SEM are shown for n=7 pigs and n=4 mice. In rep-
resentative images, endothelial cells were identified by costaining 
with anti-CD31 antibodies conjugated to fluorescein isothiocya-
nate (green). Cell nuclei were identified using TOPRO3 (blue). Dif-
ferences between means were analyzed using a paired t test.
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A
B
C
Figure 6. Cezanne stabilizes HIF1α (hypoxia-inducible factor 1α) expression under low shear stress conditions via deubiquitination. A and B, 
Human umbilical vein endothelial cells (HUVEC) were transfected using pGFP-Cezanne, pGFP-Cezanne Cys/Ser, or with pGFP alone as a control. 
Cells were subsequently exposed to low wall shear stress (WSS; 5 dyn/cm2) using the orbital system for 72 h. A, The expression levels of HIF1α 
were assessed by immunofluorescent staining. Representative images and quantification of HIF1α expression (mean±SEM) are shown. B, Cells 
were treated with MG132 (proteasome inhibitor; 50 μmol/L) and bafilomycin (lysosome inhibitor; 100 nmol/L) for the final 4 h of orbiting. HIF1α 
immunoprecipitates were tested by Western blotting using antiubiquitin (top) or anti-HIF1α (bottom) antibodies. Representative blots are shown. 
Bands were quantified by densitometry. Data were pooled from 3 independent experiments, and mean levels±SEM are shown. C, HUVEC were 
transfected with scrambled sequences or Cezanne siRNA and incubated for 24 h. Cells were exposed for 72 h to low WSS (5 dyn/cm2) using the 
orbital system. The expression levels of HIF1α and Cezanne were assessed by Western blotting using specific antibodies, and anti-PDHX (pyru-
vate dehydrogenase complex component X) antibodies were used to control for total protein levels. Representative blots are shown. Bands were 
quantified by densitometry. Data were pooled from 3 independent experiments, and mean levels±SEM are shown. A and C, Differences between 
means were analyzed using 1-way ANOVA with the Bonferroni correction for multiple pairwise comparisons (A and B) or a paired t test (C). DAPI 
indicates 4′,6-diamidino-2-phenylindole.
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A
B
C
D
Figure 7. Low shear stress enhanced glycolysis via HIF1α (hypoxia-inducible factor 1α)-dependent induction of glycolytic enzymes. A, Human 
umbilical vein endothelial cells (HUVEC) were exposed to orbital flow to generate low (5 dyn/cm2) or high (11 dyn/cm2) wall shear stress (WSS). 
After 72 h, the expression levels of hexokinase 2 (HK2), enolase 2 (ENO2), glucose transporter (GLUT) 1, GLUT3, and PFKFB3 mRNA were 
assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). B and C, HUVEC were transfected with small interfering 
RNA (siRNA) targeting HIF1α or with scrambled sequences. Cells were subsequently exposed to orbital flow to generate low WSS for 72 h. B, 
The expression levels of HIF1α, HK2, ENO2, and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) (Continued )
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regions.2–10 This was studied using cultured cells exposed to flow 
in vitro and 2 different measures of proliferation (PCNA [prolif-
erating cell nuclear antigen] and Ki67 staining). Gene silencing 
of HIF1α significantly reduced proliferation of EC exposed to 
low shear but did not alter EC exposed to high shear conditions 
(Figure 8A; Figure X in the online-only Data Supplement), 
indicating that low shear stress induces EC proliferation via 
HIF1α. The contribution of enhanced glycolysis to prolifera-
tion was assessed using 2 deoxyglucose or 3-(3-Pyridinyl)-1-
(4-pyridinyl)-2-propen-1-one (an inhibitor of PFKFB333). 
Pretreatment of EC with either compound significantly reduced 
EC proliferation under low shear stress conditions (Figure 8B; 
Figure XI in the online-only Data Supplement). Moreover, the 
expression of inflammatory molecules in EC exposed to low 
shear stress was significantly reduced by silencing of Cezanne 
(Figure VIII in the online-only Data Supplement) or pretreat-
ment of cells with 2DG (Figure 8C). Pretreatment of EC with 
2DG did not alter the expression of Cezanne or HIF1α (Figure 
XII in the online-only Data Supplement), suggesting that gly-
colysis does not feedback to control Cezanne-HIF1α signaling. 
A
B C
Figure 8. Low shear stress enhanced endothelial proliferation and inflammation via glycolysis. A, Human umbilical vein endothelial cells 
(HUVEC) were transfected with small interfering RNA (siRNA) targeting HIF1α (hypoxia-inducible factor 1α) or with scrambled sequences. 
After 24 h, cells were exposed to orbital flow to generate low (5 dyn/cm2) or high (11 dyn/cm2) wall shear stress (WSS). B, HUVEC were 
exposed to orbital flow to generate low WSS in the presence of 2 deoxyglucose (2DG; 5 mmol/L) or 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-
propen-1-one (3PO; 10 μmol/L) or dimethyl sulfoxide (DMSO) vehicle as a control. A and B, After 72 h, EC proliferation was quantified by 
immunofluorescent staining using anti-PCNA (proliferating cell nuclear antigen) antibodies and costaining using 4′,6-diamidino-2-phenyl-
indole (DAPI). Representative images are shown. The % PCNA-positive cells were calculated for multiple fields of view. C, HUVEC were 
exposed to orbital flow to generate low WSS in the presence of 2DG (5 mmol/L) or DMSO vehicle for 72 h. They were exposed to tumor 
necrosis factor α (10 ng/mL) for the final 4 h. The expression levels of VCAM-1 and PDHX (pyruvate dehydrogenase complex component 
X) were assessed by Western blotting using specific antibodies. Representative blots are shown. Bands were quantified by densitometry. 
A–C, Data were pooled from 3 independent experiments, and mean expression±SEM is shown. Differences between means were ana-
lyzed using a 2-way (A) or 1-way (B) ANOVA with the Bonferroni correction for multiple pairwise comparisons or a paired t test (C).
Figure 7 Continued. mRNA were assessed by qRT-PCR. C, The expression levels of HK2, ENO2, PFKFB3, and Calnexin were assessed by 
Western blotting using specific antibodies. Representative blots are shown. Bands in low WSS samples were quantified by densitometry. D, 
Glycolytic bioenergetics profile of HUVECs subjected to low (red trace) or high (blue trace) WSS. HUVEC were exposed to low or high WSS 
for 72 h using an orbital system. Basal glycolytic extracellular acidification rate (ECAR; green) was measured before addition of oligomycin 
to assess glycolytic capacity (purple) and subsequently 2 deoxyglucose (2DG) to assess nonglycolytic ECAR (red). ECAR traces are repre-
sentative of those generated in 3 independent experiments and are displayed as the mean of 3 wells±SEM (left). Mean glycolytic ECAR and 
glycolytic capacity±SEM are shown (right). A–D, Data were generated from 3 independent experiments, and differences between means were 
analyzed using a paired t test.
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Collectively, these data indicate that low shear stress enhances 
EC proliferation and inflammatory activation via HIF1α-
dependent induction of glycolysis enzymes.
HIF1α Promotes EC Dysfunction at Low 
Shear Stress Regions of Arteries In Vivo
We validated our in vitro observations by imposing low shear 
stress in murine carotid arteries using the partial ligation model 
that promotes arterial wall remodeling and atherosclerosis in 
hypercholesterolemic mice.25 It should be noted that low shear 
stress is not sufficient to drive vascular inflammation per se, but 
it primes ECs for enhanced responses to inflammatory stimuli.6 
Because atherosclerosis is a lipid-driven disease, we analyzed the 
function of HIF1α in partially ligated carotid arteries using hyper-
cholesterolemic mice (ApoE−/− mice exposed to a high-fat diet for 
6 weeks). We previously demonstrated by morphometry analysis 
A B
Figure 9. HIF1α (hypoxia-inducible factor 1α) induces glycolytic enzymes and inflammatory transcripts in arterial endothelium exposed to 
low shear in vivo. HIF1αEC-cKO or HIF1α+/+ mice were subjected to partial ligation of the left carotid artery (LCA), whereas the right carotid 
artery (RCA) was sham-operated as a baseline control (RCA; unligated). After surgery, mice were exposed to a Western diet for 6 wk. 
The expressions of (A) regulators of glycolysis (hexokinase 2 [HK2], enolase 2 [ENO2], glucose transporter [GLUT] 1, 6-phosphofructo-
2-kinase/fructose-2,6-biphosphatase 3 [PFKFB3]) or (B) inflammatory molecules (E-selectin, ICAM-1 [intercellular adhesion molecule 1], 
VCAM-1 [vascular cell adhesion molecule 1], MCP-1 [monocyte chemotactic protein 1]) were assessed by quantitative reverse transcrip-
tion polymerase chain reaction. Data were pooled from n=4 mice per group. Mean gene expression±SEM in the LCA is presented. Differ-
ences between mean LCA values were analyzed using an unpaired t test. Because differences between LCA and RCA values were not 
tested statistically, we have presented RCA values as a baseline comparator (normalized to 1; dotted line).
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of cross-sections and microcomputed tomography that lesion area 
in partially ligated carotid arteries was reduced by ≈50% and that 
lumen volume was increased by ≈30% in HIF1αEC-cKO ApoE−/− 
mice compared with HIF1α+/+ ApoE−/− mice.23 Correspondingly, 
it was demonstrated by morphometry of partially ligated carotid 
arteries that HIF1αEC-cKO ApoE−/− mice displayed a trend toward 
reduced total wall area compared with HIF1α+/+ ApoE−/− mice 
(HIF1αEC-cKO: 39 660±9961 μm2; HIF1α+/+: 50 495±8423 μm2; 
mean±SEM; n=5; P<0.09), whereas medial thickness was unal-
tered by HIF1α deletion from EC (HIF1αEC-cKO: 26 854±3794 
μm2; HIF1α+/+: 24 370±1097 μm2; P=0.19).
It was demonstrated by qRT-PCR (Figure 9A) and immuno-
histochemistry (Figure XIII in the online-only Data Supplement) 
that partially ligated left carotid arteries (LCA) of ApoE−/− mice 
displayed enhanced expression of several regulators of gly-
colysis compared with sham right carotid arteries. The expres-
sion of inflammatory molecules was also enhanced in partially 
ligated LCA compared with sham-operated right carotid arteries 
(Figure 9B; Figure XIII in the online-only Data Supplement). 
The function of HIF1α in low shear-driven arterial inflamma-
tion and dysfunction was studied by inducible deletion of HIF1α 
from EC. First, it was demonstrated that the expression of HIF1α 
was significantly reduced in HIF1αEC-cKO ApoE−/− mice compared 
with HIF1α+/+ ApoE−/− mice at both the mRNA and protein levels 
(Figure XIV in the online-only Data Supplement). It was subse-
quently demonstrated by qRT-PCR that the expression of glycol-
ysis regulators (Figure 9A; HK2, enolase 2, glucose transporter 
1, PFKFB3) and inflammatory molecules (Figure 9B; E-selectin, 
ICAM-1 [intercellular adhesion molecule 1], VCAM-1 [vascu-
lar cell adhesion molecule 1], MCP-1 [monocyte chemotactic 
protein 1]) in partially ligated LCA was significantly reduced 
in ApoE−/− mice that lacked endothelial HIF1α (compare 
HIF1αEC-cKO with HIF1α+/+). This concurred with immunostain-
ing that demonstrated that the expression of proteins that regu-
late glycolysis (HK2, PFKFB3; Figure 10A) or inflammation 
(ICAM-1, VCAM-1; Figure 10B) was significantly reduced in 
partially ligated LCA by endothelial deletion of HIF1α. In paral-
lel studies, we assessed the rate of EC proliferation in partially 
ligated LCA and demonstrated that this was significantly reduced 
by genetic deletion of HIF1α (Figure 10C). These data indicate 
that exposure of arteries to low shear stress leads to the activation 
of HIF1α driving glycolysis, inflammation, and EC proliferation.
In summary, mechanical shear stress induces NF-κB– and 
Cezanne-dependent upregulation of HIF1α at regions of arteries 
that are prone to atherosclerosis. HIF1α contributes to lesion ini-
tiation at atheroprone sites by activating glycolysis that enhances 
inflammation and EC proliferation. These data identify the 
Cezanne-HIF1α-glycolysis pathway as a novel mechanism con-
tributing to lesion initiation at low shear stress regions of arteries.
Discussion
Although HIF1α is canonically activated in response to hypoxia, 
here we show for the first time that mechanical low shear stress 
can activate HIF1α under normoxic conditions. The underlying 
molecular mechanism for low shear-induced HIF1α involves the 
transcription factor NF-κB that is known to be activated at low 
shear atheroprone regions.7,8 This finding is consistent with pre-
vious observations that NF-κB can induce transcription of the 
HIF1α gene in other contexts.30,31,34,35 We reasoned that a second 
mechanism should be involved because transcriptional activation 
of the HIF1α gene per se is unlikely to enhance protein levels in 
the face of PHD- and VHL-mediated degradations. We observed 
abundant expression of PHD and VHL in EC exposed to low 
shear stress, suggesting that HIF1α is hydroxylated and ubiquiti-
nated in these conditions. We, therefore, analyzed the expression 
of Cezanne, a deubiquitinating enzyme36 that can rescue HIF1α 
from VHL-mediated degradation by cleaving ubiquitin from it.32 
Cezanne was enhanced under low shear stress conditions in both 
in vitro and in vivo models, and manipulation of its activity or 
expression revealed that Cezanne enhances HIF1α expression 
at the protein level. Our collective data suggest a model where 
low shear stress enhances HIF1α via dual processes: NF-κB–
dependent induction of HIF1α mRNA and subsequent Cezanne-
dependent stabilization of HIF1α protein via ubiquitin editing. 
Our study also indicates that a functional interplay exists between 
EC mechanoresponses and hypoxia because exposure to low 
shear stress enhanced HIF1α activation in response to hypoxic 
signaling. Thus, EC at atheroprone sites are primed for responses 
to localized hypoxia, which may be caused by secondary flows 
that convect oxygen away from the arterial wall37 or from con-
sumption of oxygen by metabolically active macrophages.38
The Cezanne protein was initially described by this labora-
tory as a negative regulator of NF-κB activation downstream 
from tumor necrosis factor or interleukin-1 receptor signal-
ing.27,39 Thus, it was surprising to observe that Cezanne and 
NF-κB can co-operate to enhance HIF1α expression in low 
shear conditions. However, our subsequent studies revealed that 
silencing of Cezanne had modest effects on canonical NF-κB 
activation (RelA Ser536 phosphorylation) and did not alter non-
canonical NF-κB (measured by p100 processing to p52) in EC 
exposed to low shear stress (data not shown). Thus, we suggest 
that cross-talk between Cezanne and NF-κB may differ accord-
ing to physiological context; Cezanne can regulate NF-κB 
downstream from tumor necrosis factor α or interleukin-1 
receptors but not in response to low shear stress. Consistent 
with this, tumor necrosis factor and interleukin-1 receptors sig-
nal to NF-κB via the generation of polyubiquitin chains that 
can be dismantled by Cezanne,27,36 whereas shear stress con-
trols NF-κB via alternative pathways that may be insensitive to 
Cezanne.8,40 It is also interesting to compare our observations 
with those of Passerini et al6 who found using microarrays that 
Cezanne mRNA was enriched in the descending thoracic aorta 
(a high shear stress site) compared with the inner curvature of 
the aortic arch (low shear stress site). Further work is required 
to assess whether Cezanne regulation by shear stress differs 
between the aortic arch and thoracic descending aorta
Although it is well established that HIF1α is expressed in 
mature atherosclerotic plaques,22 its role in atherogenesis remains 
a topic of intense study. Recent work revealed that oral admin-
istration of a PHD2 inhibitor reduced lesion formation in mice 
by lowering serum cholesterol levels,41 indicating that systemic 
activation of HIF1α plays an atheroprotective role via modulation 
of lipid metabolism. However, conditional deletion or enforced 
expression of HIF1α in specific cell types revealed that the effects 
of HIF1α on atherogenesis are complex and vary according to 
cellular context. For example, expression of HIF1α in vascular 
smooth muscle cells42 or macrophages43 promoted inflammation 
in atherosclerosis, whereas HIF1α activity in CD11c-positive 
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antigen-presenting cells protected arteries from lesion formation 
by reducing T-cell infiltrates.44 Of particular note, a recent study 
revealed that HIF1α expression in EC promoted lesion formation 
by enhancing expression of proinflammatory microRNA-19a.23 
Here, we focused on the pathway that controls HIF1α expres-
sion in vascular endothelium and the downstream mechanisms 
that contribute to the initiation of atherosclerosis. Our studies 
of arteries from young mice and pigs revealed for the first time 
that HIF1α is expressed preferentially at low shear stress regions 
of the arterial tree that are predilection sites for atherosclerosis. 
Previous studies demonstrated that low shear stress promotes ath-
erosclerosis initiation by inducing high rates of EC proliferation2–4 
Figure 10. HIF1α (hypoxia-inducible factor 1α) induces glycolytic enzymes and inflammatory proteins in arterial endothelium exposed to 
low shear in vivo. HIF1αEC-cKO or HIF1α+/+ mice were subjected to partial ligation of the left carotid artery. After surgery, mice were exposed 
to a Western diet for 6 wk. Immunostaining was performed to assess the expression of the glycolysis regulators hexokinase 2 (HK2) and 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3; A), the inflammatory proteins ICAM-1  (intercellular adhesion molecule 1) 
and VCAM-1 (vascular cell adhesion molecule 1) (B), and the proliferation marker Ki67 (C) in cross-sections using DAB (3,3′-diaminobenzidine; 
brown) or NovaRed (red) substrates. n=5 mice per group were studied. Representative images are shown with arrowheads indicating EC that 
stained positive and high magnification insets. Histology scores of positive endothelial staining were pooled from 3 independent evaluations, 
and mean values±SEM are shown. Differences between means were analyzed using a Mann–Whitney test.
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that increase the permeability of arteries to cholesterol-containing 
lipoproteins10 and by activating inflammatory pathways.5–9 Our 
findings illuminate the underlying molecular mechanism by 
demonstrating that HIF1α drives inflammation and proliferation 
in low shear stress conditions. Interestingly, genetic deletion of 
HIF1α did not completely restore the expression of glycolytic 
enzymes or inflammatory molecules to the baseline value. This 
implies that although HIF1α is required for the full induction of 
glycolytic enzymes and inflammatory molecules in response to 
low shear stress, other molecules also contribute to this response 
independently from HIF1α. Thus, therapeutic targeting of HIF1α 
would be expected to dampen inflammation of arteries but not 
prevent it completely. Several signaling molecules including p534 
and JNK13 (c-jun n-terminal kinase) have been implicated in 
enhanced EC turnover at low shear stress sites, and future studies 
should determine whether these pathways cross-talk with HIF1α 
in atheroprone endothelium.
Our studies revealed that HIF1α enhances EC prolifera-
tion at low shear stress sites by inducing glycolytic enzymes to 
upregulate glycolysis. However, a recent study demonstrated that 
high shear stress reduces the rate of glycolysis in atheroprotected 
EC by activating the transcription factor KLF2 (Kruppel like 
factor 2) for transcriptional repression of PFKFB3.45 Thus, EC 
metabolism is regulated by high and low shear stress that trig-
ger opposing signaling pathways; high shear reduces glycolysis 
via KLF2, whereas low shear enhances it via HIF1α. It is well 
established that HIF1α-dependent glycolysis plays an essential 
role during angiogenesis because it allows rapid ATP generation 
under hypoxic conditions and produces intermediates for macro-
molecule synthesis, thus promoting EC proliferation and migra-
tion.19–21 This pathway is important in tumor vascularization, and 
clinical trials are underway to test the ability of glycolysis inhibi-
tors to treat cancer.46 Now, we show for the first time that this 
pathway is activated in adult arteries, specifically at atheroprone 
sites where it contributes to lesion initiation by promoting exces-
sive EC proliferation and inflammation. It is likely that glycolysis 
also contributes to the progression of atherosclerosis, and it has 
recently been linked to inflammation in coronary artery disease.47
In summary, we demonstrate for the first time that HIF1α 
can be activated mechanically by low shear stress. This non-
canonical pathway, which requires activation of NF-κB and 
Cezanne, promotes HIF1α accumulation at atheroprone sites 
leading to excessive EC proliferation and focal inflammation. 
Thus, the mechanically activated Cezanne-HIF1α axis contrib-
utes to the initiation of lesions at branches and bends and may 
provide a novel therapeutic target to promote vascular function.
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Highlights
• HIF1α (hypoxia-inducible factor 1α) can be activated by mechanical shearing of arterial endothelial cells in the presence of oxygen, a nonca-
nonical mechanism that promotes HIF1α accumulation at atheroprone sites.
• The underlying mechanism involves dual processes; nuclear factor-κB–dependent induction of HIF1α mRNA and stabilization of HIF1α protein 
by the ubiquitin-editing enzyme Cezanne.
• HIF1α promotes atherogenic processes at low shear stress regions by inducing excessive endothelial proliferation and inflammation via 
upregulation of glycolysis.
• Thus, noncanonical mechanical activation of HIF1α plays an important role in focal endothelial dysfunction and has the potential to be targeted 
therapeutically to enhance vascular function.
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MATERIALS AND METHODS 
 
Isolation of EC from porcine aortae. Pig aortas from 4-6 month old animals 
(weight approximately 80kg) were obtained immediately after slaughter from a 
local abattoir. They were cut longitudinally along the outer curvature to expose the 
lumen. EC exposed to high (outer curvature) or low (inner curvature) wall shear 
stress (WSS) were harvested using collagenase (1 mg/ml for 10 minutes at room 
temperature) prior to gentle scraping.  
 
Mouse lines. Mice were housed under specific-pathogen free conditions. All 
animal experiments were reviewed and approved by the local authorities in 
accordance with German animal protection law. HIF1a was deleted from 
endothelial cells (EC) of ApoE-/- mice by crossing Hif1aflox/flox ApoE-/- mice VE-Cad-
Cre-ERT2 mice which express Tamoxifen-activated Cre under control of the VE-
cadherin promoter as described1. Experiments were carried out using female mice 
because vascular physiology varies between sexes in mice with females having 
more pronounced and less variable pathophysiological features2. Thus female 
VE-Cad-Cre-ERT2/ Hif1aflox/flox/ ApoE-/- conditional knockout mice (called HIF1aEC-
cKO) and VE-Cad-Cre-ERT2/ Hif1a+/+/ ApoE-/- (HIF1a+/+) mice were treated with 
tamoxifen (2 mg/20 g body weight) dissolved in neutral oil via intraperitoneal (i.p.) 
injections for 5 consecutive days. After one week, mice aged 6-8 weeks were 
anesthetized (ketamine (80 mg/kg, i.p.), xylazine (10 mg/kg, i.p.)) and the left 
carotid artery was partially ligated by closing the external, internal and the 
occipital artery restricting blood outflow to the superior thyroid artery only as 
described3. The right carotid artery was sham-operated as a control. Mice were 
fed a high fat diet (0.15% cholesterol) for 6 weeks.  
 
Staining of murine endothelium. The expression levels of specific proteins were 
assessed in EC at regions of the inner curvature (susceptible site) and outer 
curvature (protected site) of murine aortae by en face staining. Animals were 
killed by I.P injection of pentobarbital or by isofluorane overdose. Aortae were 
perfused in situ with PBS (at a pressure of approximately 100 mm Hg) and then 
perfusion-fixed with 4% Paraformaldehyde prior to harvesting. Fixed aortae were 
tested by immunostaining using specific primary antibodies and Alexafluor568-
conjugated secondary antibodies (red). EC were identified by co-staining using 
anti-CD31 antibodies conjugated to the fluorophore FITC (green). Nuclei were 
identified using a DNA-binding probe with far-red emission (To-Pro-3). Stained 
vessels were mounted prior to visualization of endothelial surfaces en face using 
confocal laser-scanning microscopy (Zeiss LSM510 NLO inverted microscope). 
Isotype-matched monoclonal antibodies raised against irrelevant antigens or pre-
immune rabbit sera were used as experimental controls for specific staining. The 
expression of particular proteins at each site was assessed by quantification of 
fluorescence intensity for multiple cells (at least 50 per site) using Image J (1.49p) 
and calculation of mean fluorescence intensities with standard error of the mean.  
 
Consecutive sections at an interval of 120 μm made from experimental carotid 
arteries were immunostained using specific primary antibodies. Non-specific IgG 
served as a negative control. Primary antibodies were detected using horse radish 
peroxidase-conjugated secondary antibodies and 3,3-diaminobenzidine (DAB; 
brown) or NovaRed (red) substrates (Vector Laboratories, Burlingame, CA, USA). 
Sections were counterstained using haematoxylin and eosin. The extent of EC 
staining in cross-sections was scored by 3 researchers blinded to the 
experimental conditions. Lesions were identified in carotid arteries by elastic van 
Gieson staining of serial sections (4–5 μm thick) at an interval of 100 μm, and the 
total vessel area and medial area were calculated by morphometry using Image J 
software. 
 
EC culture and exposure to WSS. HUVEC were isolated using collagenase 
digestion. Cells were cultured on 1% gelatin and maintained in M199 growth 
medium supplemented with foetal bovine serum (20%), L-glutamine (4 mmol/L), 
endothelial cell growth supplement (30 µg/ml), penicillin (100 U/ml), streptomycin 
(100 µg/ml) and heparin (10 IU/ml). Human coronary artery EC (HCAEC) were 
purchased from PromoCell and cultured according to the manufacturer’s 
recommendations. EC at passage 3-5 were cultured until confluent in 6 well plates 
and exposed to flow using an orbital shaking platform (PSU-10i; Grant 
Instruments) housed inside a cell culture incubator. The radius of orbit of the 
orbital shaker was 10 mm and the rotation rate was set to 210 rpm. This motion 
caused swirling of the culture medium over the cell surface generating low WSS 
(approximately 5 dynes/cm2) with varied directionality at the centre and high 
(approximately 11 dynes/cm2) WSS with uniform direction at the periphery. 
Alternatively, HUVEC were cultured on Ibidi® gelatin-coated µ-Slides (Ibidi 
GmbH) until they reached confluency. Flowing medium was then applied using 
the Ibidi® pump system to generate low (4 dyn/cm2), low oscillatory (+/- 4 
dyn/cm2, 0.5 Hz) or high (13 dyn/cm2) WSS. The slides and pump apparatus were 
enclosed in a cell culture incubator warmed to 37°C. 
 
Gene silencing and overexpression.  Cell cultures were transfected with siRNA 
sequences that are known to silence HIF1a (Dharmacon SMARTpool: ON-
TARGETplus L-004018-00-0005, Dharmacon  Individual: ON-TARGETplus J-
004018-08-0002), RelA (Dharmacon  SMARTpool: ON-TARGETplus L-003533-
00-0005) or Cezanne (Dharmacon siGENOME D-008670-03) using the 
Lipofectamine® RNAiMAX transfection system (13778-150, Invitrogen) following 
the manufacturer’s instructions. Alternatively, cells were transfected with the 
Neon™ Transfection system (Invitrogen; 1200 volts, 40 ms, 1 pulse). Final siRNA 
concentration used was 25nM for lipofectamine4 and 50 mm by electroporation. 
After knockdown, cells were then incubated in complete M199 growth medium for 
2 h before exposure to flow. Non-targeting scrambled sequences were used as a 
control (D-001810-01-50 ON-TARGETplus Non targeting siRNA#1, Dharmacon). 
HUVEC were transfected with expression vectors containing IkBa (pCMV-IkBa, 
GFP-Cezanne or GFP-Cezanne Cys/Ser (catalytically inactive)5 using 
Lipofectamine (ThermoFisher).  
 
Comparative real time PCR. RNA was extracted using the RNeasy Mini Kit 
(74104, Qiagen) and reverse transcribed into cDNA using the iScript cDNA 
synthesis kit (1708891, Bio-Rad). The levels of human, porcine or murine 
transcripts were assessed using quantitative real time PCR (qRT-PCR) using 
gene-specific primers (Supplementary Table 1). Reactions were prepared using 
SsoAdvanced universal SYBR®Green supermix (172-5271, Bio-rad) and following 
the manufacturer’s instructions, and were performed in triplicate. Relative gene 
expression was calculated by comparing the number of thermal cycles that were 
necessary to generate threshold amounts of product. Fold changes were 
calculated using the ΔΔCt method. Data were pooled from at least three 
independent experiments and mean values were calculated with SEM. 
 
Immunoprecipitation of HIF1a. Cells were lysed using ice-cold lysis buffer (50 
mM Tris (pH 7.4), 250 mM NaCl, 0.3% Triton X-100, 1mM EDTA, 10µM MG132) 
supplemented with protease inhibitor cocktail (Roche, Basel, Switzerland). 
Lysates were subjected to three freeze-thaw cycles before immunoprecipitation 
using anti-HIF1a antibodies. Beads were then washed extensively using lysis 
buffer.  
 
Western	 blotting	 Total	 cell	 lysates were isolated using lysis buffer (containing 2% 
SDS, 10% Glycerol and 5% β-mercaptoethanol). Western blotting was carried out 
using specific antibodies against HIF1a, HIF2a, Cezanne, IkBa, HK2, ENO2, 
PFKFB3, VCAM-1, PDHX, Calnexin (Supplementary Table 2) and horse radish 
peroxidase-conjugated secondary antibodies obtained commercially from Dako 
and chemiluminescent detection was carried out using ECL Prime® (GE 
Healthcare).  
 
Chromatin immunoprecipitation. A commercial kit was used (Cell Signaling 
Technology). HUVECs were fixed using formaldehyde and nuclei were purified 
and subjected to sonication. For immunoprecipitation reactions, the nuclear 
lysates were incubated overnight at 4oC with protein G magnetic beads coated 
with either anti-RelA (sc-372; Santa Cruz) or with anti-histone H3 antibodies or 
isotype-matched IgG control (both from Cell Signaling Technology). 
Immunocomplexes were washed, and co-precipitating DNA fragments were 
quantified by real-time PCR using specific DNA primers (Supplementary Table 1). 
Immunofluorescent staining of cultured EC.  The expression levels of proteins 
were assessed by immunostaining using specific antibodies followed by widefield 
fluorescence microscopy (LeicaDMI4000B). HUVEC were fixed with 
Paraformaldehyde (4%) and permeabilised with Triton X-100 (0.1%). Following 
blocking with goat serum for 30 min monolayers were incubated for 16 h with 
primary antibodies against HIF1a, PCNA (proliferation marker) or Ki67 
(proliferation marker) and AlexaFluor488- or Alexafluor568-conjugated secondary 
antibodies. Nuclei were identified using the DNA-binding probe DAPI (Sigma). 
Image analysis was performed using Image J software (1.49p) to calculate 
average fluorescence. Isotype controls or omission of the primary antibody was 
used to control for non-specific staining. 
 
Glycolysis assay. HUVEC were plated in a Cell Tak-coated Seahorse cell culture 
plate in XF assay media pH 7.4 (Seahorse Bioscience) supplemented with 2 mM 
glutamine and 25 mM glucose. Extracellular acidification rate (ECAR) was 
measured basally prior to addition of oligomycin to assess glycolytic capacity. 
After reading basic ECAR and maximum ECAR induced by oligomycin, glycolysis 
was suppressed via addition of 2 deoxyglucose (2DG) thus allowing measurement 
of non-glycolytic ECAR as described6. Glycolytic ECAR was calculated by taking 
the ECAR value prior to oligomycin injection and subtracting the ECAR value in 
the presence of 2DG. Glycolytic capacity was calculated by subtracting ECAR in 
the presence of oligomycin from ECAR in the presence of 2DG.  
 
Statistics. Differences between samples were analysed using an unpaired or 
paired Student’s t-test or ANOVA with the Bonferonni correction for multiple 
pairwise comparisons.  
 
 
  
 
 
 
 
 
Supplementary Table 1 PCR primers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mouse	 Forward			5'-3'	 Reverse			5'-3'	
Mouse	HK2	 TCGCATATGATCGCCTGCTTA TCTGAGAGACGCATGTGGTAG	
Mouse	ENO2	 GAGAAGATTTGGGCCCGAGAG	 CGGAAAAGACCTTTGGCAGT	
MouseGLUT1	 GGATCACTGCAGTTCGGCTA	 AGCGGTGGTTCCATGTTTGA	
Mouse	PFKFB3	 GAAGCTGACTCGCTACCTCA	 TGTACTGCTTCACAGCCTCA	
Mouse	MCP1	 CTGGAGCATCCACGTGTTGG	 CAGCTTCTTTGGGACACCTG	
Mouse	ICAM1	 CCCTGGTCACCGTTGTGAT	 GAACAGTTCACCTGCACGGAC	
Mouse	VCAM1	 TGGGAGCCTCAACGGTACTT	 AGCAATCGTTTTGTATTCAGGGG	
Mouse	E-selectin	 GAATGCCTCGCGCTTTCTCT	 GAGCTCACTGGAGGCATTGTA	
		
Pig	 Forward			5'-3'	 Reverse			5'-3'	
Pig	HIF1α	 TGGTACTCACAGATGATGGTGAC	 CATTTCCTCATGGTCGCACG	
Pig	HK2	 GAACACGGAGAGTTCCTGGC	 CCTTCTGGAGTCCGTTGTCT	
Pig	ENO2	 GGCCTCTCTGTGGTGGAAC	 ATTGGCCCCAAACTTGGACT	
Pig	GLUT1	 GGCATCAACGCGGTTTTCTAT	 AGACTCACCGACACGACAGT	
Pig	GLUT3	 TGCTCCTGAGGCGATCATAAA	 GACCACAGGGACGTGAGTAA	
Pig	PFKFB3	 CTGACCCGCTACCTCAACTG	 AGGAGCTGTACTGCTTGACG	
		
HUMAN	 Forward			5'-3'	 Reverse			5'-3'	
Human	HIF1α	 TGGTTCTCACAGATGATGGTGAC	 CTCATTTCCTCATGGTCACATGG	
Human	HK2	 TCACGGAGCTCAACCATGAC	 GCTCCAAGCCCTTTCTCCAT	
Human	ENO2	 CCACAGTGGAGGTGGATCTCT TCATAGATGCCCGTAGAGGCT	
Human	GLUT1	 TCCCTGCAGTTTGGCTACAA	 CAGGATGCTCTCCCCATAGC	
Human	GLUT3	 CTCTTCGTCAACCGCTTTGG	 CCCATAAAGCAGCCACCAGT	
Human	PFKFB3	 CCGTTGGAACTGACGCAGA	 CACAGGATCTGGGCAACGAG	
Human	Cezanne	 GAGTTGAGAAGGAAGCGTT	 CACTCCTTCTGCCATTCATC	
Human	HIF1A	
promoter	 CTTCGGAGAAGGCGCAGAGT	 GTGCTCGTCTGTGTTTAGCG	
 
 
 
 
 
 
 
Supplementary Table 2 Antibodies: suppliers and concentrations used. 
 
Antibody	 Company	 Use	 Dilution	Ratio		
Final	
Concentration	
HIF1α	 Mouse	monoclonal	Anti-Human	HIF-1α,	610959,	BD	Biosciences	 WB	 1/500	 5μg/ml	
HIF1α	 Rabbit	monoclonal	antibody	to	HIF1α,	ab51608,	Abcam		 IF	 1/100	 10μg/ml	
VCAM1	 Rabbit	monoclonal	anti-VCAM1	antibody,	Ab134047,	Abcam		
WB	 1/5000	 80ng/ml	
ICC	 1/200	 2μg/ml	
PCNA	 Rabbit	polyclonal	anti-	PCNA	antibody,	Ab18197,	Abcam		 IF	 1/100	 2μg/ml	
PFKFB3	 Rabbit	 monoclonal	 anti-	 PFKFB3	 antibody,	Ab181861,	Abcam	
WB	 1/3000	 0.2μg/ml	
ICC	 1/100	 5μg/ml	
ENO2	 Rabbit	polyclonal	NSE/ENO2	Antibody	[NB100-91898],	Novus	 WB	 1/2000	 0.5μg/ml	
HK2	 Rabbit	polyclonal	Hexokinase	II	Antibody	[NBP2-16814],	Novus	
WB	 1/5000	 0.2μg/ml	
IF	 1/200	 5μg/ml	
HIF2α	 Abcam,	Rabbit	polyclonal	anti-HIF-2-alpha	antibody,	Ab199	 WB	 1/1000	 1μg/ml	
ICAM1	 Rabbit	polyclonal	anti-ICAM1	antibody,	10020-I-AP,	ProteinTech	 ICC	 1/250	 5μg/ml	
PDHX	 Rabbit	polyclonal	E3BP(PDHX)	antibody,	sc-98751,	Santa	Cruz	 WB	 1/5000	 40ng/ml	
Calnexin	 Mouse	monoclonal	Anti-calnexin,	610524,	BD	Biosciences	 WB	 1/5000	 50ng/ml	
Cezanne	 Rabbit	polyclonal	to	OTUD7B,	16605-I-AP,	ProteinTech	
WB	 1/3000	 50ng/ml	
IF	 1/100	 2.5μg/ml	
Ki67	 Rabbit	polyclonal	to	Ki67,	ab15580,	Abcam	 IF	 1/100	 5μg/ml	
 
WB,	Western	blotting;	IF,	immunofluorescence;	ICC,	immunocytochemistry.	
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Supplementary Figure I. Low magnification images of en face staining of 
HIF1a and Cezanne in the murine aorta. 
The expression of HIF1a (A) and Cezanne (B) was assessed at low shear stress 
(inner curvature) and high shear stress (outer curvature) regions of the murine aorta 
by en face staining. EC were identified by co-staining with anti-CD31 antibodies 
conjugated to FITC (green). Cell nuclei were identified using TOPRO3 (blue). 
Regions exposed to high and low shear stress were identified by anatomical 
landmarks and confirmed by assessment of nuclei which are aligned specifically 
under high shear stress. Images representing tiling of multiple fields of view are 
presented. Note the distinct difference in HIF1a and Cezanne expression between 
high and low shear stress regions (delineated by a broken white line). Scale bar, 20 
µm. 
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Supplementary Figure II. HIF1a is expressed by endothelial cells overlying 
plaques at low shear stress regions.  
ApoE-/- mice aged 8 weeks were exposed to a high fat diet for 6 weeks (n=4). 
C57BL/6 (wild-type) mice aged 14 weeks were also studied (n=4). The expression of 
HIF1a was quantified at a low wall shear stress region (inner curvature) by en face 
staining. EC were identified by co-staining with anti-CD31 antibodies conjugated to 
FITC (green). Cell nuclei were identified using TOPRO3 (blue). A representative 
image of HIF1a expression in EC overlying a plaque in the ApoE-/- model is shown 
(left). Mean levels of HIF1a expression (+/- SEM) were calculated for ApoE-/- and 
wild-type mice (right). Differences between means were analysed using a paired t-
test. n.s., not significant. 
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Supplementary Figure III. Validation of HIF1a siRNA. 
HUVEC were transfected with siRNA targeting HIF1a or with scrambled sequences. 
After 24 h, cells were exposed to DMOG for 4 h. The expression levels of HIF1a and 
HIF2a were assessed by Western blotting using specific antibodies, and anti-
Calnexin antibodies were used to control for total protein levels. Representative blots 
are shown.  
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Supplementary Figure IV. Endothelial cells exposed to low shear stress in 
atmospheric oxygen were not hypoxic. 
HUVEC were exposed to orbital flow to generate low (5 dyn/cm2) or high (11 
dyn/cm2) wall shear stress (WSS) either within a hypoxic chamber (1% O2) or under 
atmospheric levels O2. After 72 h, the cells were treated with Pimonidazole (60 ng/ml) 
for 90 min before fixation with 4% PFA and staining using rabbit polyclonal anti-
pimonidazole antibodies. Hypoxic cells were assessed by Pimonidazole staining 
(red). Cell nuclei were identified using DAPI (blue). 
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Supplementary Figure V.  Low shear stress induced HIF1a mRNA in 
coronary artery EC.  
Human coronary artery EC were exposed to low (5 dyn/cm2) or high (11 dyn/cm2) 
wall shear stress (WSS) for 72 h using an orbital system or were exposed to static 
conditions. HIF1a mRNA was quantified by qRT-PCR. Data were pooled from three 
different donors and mean HIF1a expression levels +/- SEM are shown. Differences 
between means were analysed using a 1-way ANOVA with the Bonferroni correction 
for multiple pairwise comparisons. 
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Supplementary Figure VI. Validation of enforced IkBa expression. 
HUVEC were transfected with pCMV-IkBa to inhibit NF-kB or with an empty plasmid 
as a control. After 24 h, the expression levels of IkBa and VCAM-1 were assessed by 
Western blotting using specific antibodies, and anti-Calnexin antibodies were used to 
control for total protein levels. Representative blots are shown.  
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Supplementary Figure VII. Validation of antibodies used to detect Cezanne 
by Western blotting. 
HUVEC were transfected with siRNA targeting Cezanne or with scrambled 
sequences. Cells were then exposed to orbital flow to generate low WSS (5 dyn/cm2). 
After 72 h, the expression levels of Cezanne were assessed by Western blotting 
using specific antibodies, and anti-PDHX antibodies were used to control for total 
protein levels. Representative blots are shown. 
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Supplementary Figure VIII. Cezanne positively regulates the expression of 
glycolysis genes and inflammatory molecules in EC exposed to low shear 
stress.  
HUVEC were transfected with siRNA targeting Cezanne or with scrambled 
sequences. Cells were subsequently exposed to orbital flow to generate low WSS (5 
dyn/cm2) for 72 h. The expression levels of Cezanne, HIF1a (A) or HK2, ENO2, 
PFKFB3, VCAM-1, ICAM-1, E-selectin, IL-8 and MCP1 (B) mRNA were assessed by 
qRT-PCR. Data were generated from three independent experiments and differences 
between means were analysed using a paired t-test. 
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Supplementary Figure IX. Low shear stress primed EC for hypoxic 
signaling. 
HUVEC were exposed to orbital flow to generate low (5 dyn/cm2) or high (11 
dyn/cm2) wall shear stress (WSS). After 72h, cells were treated with DMOG for 4 h.  
The expression levels of HK2, ENO2 and PFKFB3 were assessed by Western 
blotting using specific antibodies, and anti-Calnexin antibodies were used to control 
for total protein levels. (A) Representative blots are shown. (B) Bands were quantified 
by densitometry. Data were pooled from three independent experiments and mean 
expression +/- SEM is shown. Differences between means were analysed using a 2-
way ANOVA with the Bonferroni correction for multiple pairwise comparisons. 
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Supplementary Figure X. Low shear stress enhanced endothelial 
proliferation (Ki67 staining) via HIF1a. 
HUVEC were transfected with siRNA targeting HIF1a or with scrambled sequences. 
After 24 h, cells were exposed to orbital flow to generate low (5 dyn/cm2) or high (5 
dyn/cm2) shear stress. After 72 h, EC proliferation was quantified by 
immunofluorescent staining using anti-Ki67 antibodies and co-staining using DAPI. 
Representative images are shown. The % Ki67-positive cells were calculated for 
multiple fields of view. Data were pooled from three independent experiments and 
mean expression +/- SEM is shown. Differences between means were analysed 
using a 2-way ANOVA with the Bonferroni correction for multiple pairwise 
comparisons. 
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Supplementary Figure XI.  Low shear stress enhanced endothelial 
proliferation (Ki67 staining) via glycolysis. 
HUVEC were exposed to orbital flow to generate low shear stress (5 dyn/cm2) in the 
presence of 2DG (5 mM) or 3PO (10 µM) or DMSO vehicle as a control. After 72 h, 
EC proliferation was quantified by immunofluorescent staining using anti-Ki67 
antibodies and co-staining using DAPI. Representative images are shown. The % 
Ki67-positive cells were calculated for multiple fields of view. Data were pooled from 
three independent experiments and mean expression +/- SEM is shown. Differences 
between means were analysed using a 1-way ANOVA with the Bonferroni correction 
for multiple pairwise comparisons. 
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Supplementary Figure XII. FDG treatment did not alter the expression of 
Cezanne or HIF1a in EC. 
HUVEC were exposed to FDG for 24 h or 72 h or remained untreated as a control. 
The expression levels of HIF1a and Cezanne were assessed by Western blotting 
using specific antibodies, and anti-PDHX antibodies were used to control for total 
protein levels. Representative blots are shown. Bands were quantified by 
densitometry. Data were pooled from three independent experiments and mean 
levels +/- SEM are shown. Differences between means were analysed using 1-way 
ANOVA with the Bonferroni correction for multiple pairwise comparisons. n.s., not 
significant. 
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Supplementary Figure XIII. Glycolytic enzymes, inflammatory proteins and 
proliferation were induced by low shear in vivo. ApoE-/- mice were subjected to 
partial ligation of the left carotid artery (LCA). After surgery, mice were exposed to a 
Western diet for 6 weeks. Immunostaining was performed to assess the expression 
of the glycolysis regulator HK2, the inflammatory proteins ICAM-1 and VCAM-1, and 
the proliferation marker Ki67 in cross-sections using DAB (brown) or NovaRed (red) 
substrates. n=4 mice per group were studied. Representative images are shown. 
Histology scores of positive endothelial staining were pooled from 3 independent 
evaluations and mean values +/- SEM are shown. Differences between means were 
analysed using a Mann Whitney test.  
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Supplementary Figure XIV. Validation of inducible HIF1a genetic deletion from 
EC. 
HIF1aEC-cKO or HIF1a+/+ mice were subjected to partial ligation of the left carotid 
artery. After surgery, mice were exposed to a Western diet for 6 weeks. (A) The 
expression of HIF1a was assessed by qRT-PCR. Data were pooled from n=4 mice 
per group. Differences between means were analysed using an unpaired t-test. (B) 
Immunostaining was performed to assess the expression of HIF1a protein in cross-
sections using NovaRed (red) substrate. n=5 mice per group were studied. 
Representative images are shown with arrowheads indicating EC that stained 
positive and high magnification insets. Histology scores of positive endothelial 
staining were pooled and mean values +/- SEM are shown. Differences between 
means were analysed using a Mann Whitney test. 
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